3-methyl-pyrrolidine-2,5-dione derivatives useful as CGRP receptor antagonists
US10336726B2 · kind B2 · utility
1Cited by
4References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 8, 2018 |
| Grant date | Jul 2, 2019 |
| Priority date | — |
| Expiry date | May 8, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a compound of Formula II: or a pharmaceutically acceptable salt or hydrate thereof, useful as a CGRP receptor antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.